Ryan Martins

Ryan Martins

Director of Finance/CFO presso 89BIO, INC.

Patrimonio netto: 1 M $ in data 29/02/2024

47 anni
Health Technology
Finance
Consumer Services

Profilo

Currently, Ryan Stephen Martins is Chief Financial Officer at 89bio, Inc. In his past career Mr. Martins held the position of Chief Financial Officer for Revolution Medicines, Inc., VP-Corporate Strategy & Investor Relations at Ultragenyx Pharmaceutical, Inc., Principal at Chiron Corp., Associate at Lehman Brothers, Inc., Senior Biotechnology Analyst at Jefferies LLC, Vice President at Barclays Capital, Inc. and Senior Biotechnology Analyst at FM Partners Holdings LLC.
Mr. Martins received a graduate degree from Virginia Polytechnic Institute & State University, a graduate degree and an undergraduate degree from the University of Mumbai, an MBA from Haas School of Business and an undergraduate degree from St. Xavier's College.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
17/02/2024 106 609 ( 0.12% ) 1 M $ 29/02/2024

Posizioni attive di Ryan Martins

SocietàPosizioneInizio
89BIO, INC. Director of Finance/CFO 01/07/2019
Tutte le posizioni attive di Ryan Martins

Precedenti posizioni note di Ryan Martins

SocietàPosizioneFine
REVOLUTION MEDICINES, INC. Director of Finance/CFO 01/10/2018
ULTRAGENYX PHARMACEUTICAL INC. Investor Relations Contact 01/03/2018
Analyst-Equity 01/07/2015
Analyst-Equity 31/01/2014
Analyst-Equity -
Vedi nel dettaglio l'esperienza di Ryan Martins

Formazione di Ryan Martins

Virginia Polytechnic Institute & State University Graduate Degree
University of Mumbai Graduate Degree
Haas School of Business Masters Business Admin
St. Xavier's College Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ryan Martins

Relazioni

100 +

Relazioni di 1° grado

12

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
ULTRAGENYX PHARMACEUTICAL INC.

Health Technology

REVOLUTION MEDICINES, INC.

Health Technology

89BIO, INC.

Health Technology

Aziende private5

Health Technology

Finance

Finance

Finance

Finance

Vedi le connessioni aziendali
  1. Borsa
  2. Insiders
  3. Ryan Martins